Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F. & Bell, B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45, 529–538 (2006).
Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1, e00049 (2012).
Li, H. et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol. Immunol. 11, 175–183 (2014).
Tuttleman, J. S., Pourcel, C. & Summers, J. Formation of the pool of covalently closed circular viral-DNA in hepadnavirus-infected cells. Cell 47, 451–460 (1986).
Tong, S. P. & Revill, P. Overview of hepatitis B viral replication and genetic variability. J. Hepatol. 64, S4–S16 (2016).
Newbold, J. E. et al. The covalently closed duplex form of the hepadnavirus genome exists in-situ as a heterogeneous population of viral minichromosomes. J. Virol. 69, 3350–3357 (1995).
Ghany, M. & Liang, T. J. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132, 1574–1585 (2007).
Perrillo, R. Benefits and risks of interferon therapy for hepatitis B. Hepatology 49, S103–S111 (2009).
Wieland, S. F., Asabe, S., Engle, R. E., Purcell, R. H. & Chisari, F. V. Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver. J. Virol. 88, 5184–5188 (2014).
Tan, G. Y., Song, H. X., Xu, F. C. & Cheng, G. H. When hepatitis B virus meets interferons. Front. Microbiol. 9, 1611 (2018).
Smibert, C. A., Wilson, J. E., Kerr, K. & Macdonald, P. M. Smaug protein represses translation of unlocalized nanos mRNA in the Drosophila embryo. Gene Dev. 10, 2600–2609 (1996).
Aviv, T., Lin, Z., Ben-Ari, G., Smibert, C. A. & Sicheri, F. Sequence-specific recognition of RNA hairpins by the SAM domain of Vts1p. Nat. Struct. Mol. Biol. 13, 168–176 (2006).
Baez, M. V. & Boccaccio, G. L. Mammalian smaug is a translational repressor that forms cytoplasmic foci similar to stress granules. J. Biol. Chem. 280, 43131–43140 (2005).
Baez, M. V. et al. Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation. J. Cell Biol. 195, 1141–1157 (2011).
Fernandez-Alvarez, A. J., Pascual, M. L., Boccaccio, G. L. & Thomas, M. G. Smaug variants in neural and non-neuronal cells. Commun. Integr. Biol. 9, e1139252 (2016).
de Haro, M. et al. Smaug/SAMD4A restores translational activity of CUGBP1 and suppresses CUG-induced myopathy. PLoS Genet. 9, e1003445 (2013).
Chen, Z. et al. Mutation of mouse Samd4 causes leanness, myopathy, uncoupled mitochondrial respiration, and dysregulated mTORC1 signaling. Proc. Natl Acad. Sci. USA 111, 7367–7372 (2014).
Niu, N. N. et al. RNA-binding protein SAMD4 regulates skeleton development through translational inhibition of Mig6 expression. Cell Discov. 3, 16050 (2017).
Zhang, Y. L. et al. Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus. Emerg. Microbes Infect. 8, 724–733 (2019).
Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl Acad. Sci. USA 99, 15655–15660 (2002).
Wu, Y. et al. Sleeping beauty transposon-based system for rapid generation of HBV-replicating stable cell lines. J. Virol. Methods 234, 96–100 (2016).
Zhang, T. Y. et al. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut 65, 658–671 (2016).
Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009).
Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36–49 (2014).
Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–U545 (2011).
Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–U514 (2007).
Kuriakose, T. et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 1, aag2045 (2016).
Chen, Q. Y. et al. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication. World J. Gastroenterol. 18, 2850–2858 (2012).
Wang, W. H., Studach, L. L. & Andrisani, O. M. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology 53, 1137–1147 (2011).
Tavalai, N., Papior, P., Rechter, S. & Stamminger, T. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82, 126–137 (2008).
Regad, T. & Chelbi-Alix, M. K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274–7286 (2001).
Mao, R. C. et al. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 9, e1003494 (2013).
Mao, R. C. et al. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J. Virol. 85, 1048–1057 (2011).
Liu, Y. J. et al. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog. 13, e1006296 (2017).
Li, J. H. et al. Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of Pre-S/S RNAs. J. Virol. 84, 6387–6399 (2010).
Wang, H. F., Kim, S. & Ryu, W. S. DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 83, 5815–5824 (2009).
Nelson, M. R., Leidal, A. M. & Smibert, C. A. Drosophila Cup is an eIF4E-binding protein that functions in Smaug-mediated translational repression. EMBO J. 23, 150–159 (2004).
Brodsky, L. I. et al. A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients. PLoS ONE 2, e584 (2007).
Aviv, T. et al. The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Nat. Struct. Biol. 10, 614–621 (2003).
Nishimura, T. et al. The eIF4E-binding protein 4E-T is a component of the mRNA decay machinery that bridges the 5′ and 3′ termini of target mRNAs. Cell Rep. 11, 1425–1436 (2015).
Semotok, J. L. et al. Smaug recruits the CCR4/POP2/NOT deadenylase complex to trigger maternal transcript localization in the early drosophila embryo. Curr. Biol. 15, 284–294 (2005).
Zaessinger, S., Busseau, I. & Simonelig, M. Oskar allows nanos mRNA translation in Drosophila embryos by preventing its deadenylation by Smaug/CCR4. Development 133, 4573–4583 (2006).
Huang, L. R., Wu, H. L., Chen, P. J. & Chen, D. S. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl Acad. Sci. USA 103, 17862–17867 (2006).
Yang, P. L., Althage, A., Chung, J. & Chisari, F. V. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl Acad. Sci. USA 99, 13825–13830 (2002).
Zhou, W. et al. Predictive model for inflammation grades of chronic hepatitis B: large-scale analysis of clinical parameters and gene expressions. Liver Int. 37, 1632–1641 (2017).
Hubel, P. et al. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat. Immunol. 20, 493–49 (2019).
Pollack, J. R. & Ganem, D. An RNA stem-loop structure directs hepatitis-B virus genomic RNA encapsidation. J. Virol. 67, 3254–3263 (1993).
Sato, S. et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123–132 (2015).